Bicuspid Aortic Valve in Heritable Thoracic Aortic Disease: Insights from the Montalcino Aortic Consortium
Authors:
- Kishan L. AsokanKAKishan L. Asokan
- Neha MuralyNMNeha Muraly
- Dongchuan GuoDGDongchuan Guo
- Deep M. ShahDSDeep M. Shah
- Ernesto C. MartinezEMErnesto C. Martinez
- Julie De BackerJBJulie De Backer
- Laura Muiño MosqueraLMLaura Muiño Mosquera
- Wannes RendersWRWannes Renders
- Alan C. BravermanABAlan C. Braverman
- Michelle LimMLMichelle Lim
- Maral OuzonianMOMaral Ouzonian
Preprint
Abstract
Bicuspid aortic valve (BAV) is the most common congenital heart malformation and predisposes to thoracic aortic aneurysms. The Montalcino Aortic Consortium (MAC) registry collects genetic and phenotypic data on individuals with heritable thoracic aortic disease genes (HTAD PVs) that primarily regulate smooth muscle cell contraction or TGF-β signaling (TGF-β PVs, termed Loeys-Dietz Syndrome (LDS)). We evaluated associations between BAV, HTAD PVs and aortic outcomes in the MAC cohort. BAV was present in 48 (6%) of 816 MAC participants (age 38 [IQR 20-52] years, 51% female) and was not significantly increased in males or in the entire TGF-β PV group (417 with TGF-β PVs, p=0.14) but was enriched in participants with TGFBR1 or TGFBR2 PVs (16/168, 10% vs. 32/648, 5%, PR 1.93 [1.08, 3.43], pP< 0.001), younger age at first aortic event (24 vs. 40 years, p0.5). Sinus of Valsalva dilation (Z>3, 25/48, 52% vs. 128/768, 17%, P< 0.0001) and ascending aorta dilation (Z>3, 12/48, 25% vs. 26/768, 3%, P< 0.0001) were more common in participants with BAV. Participants with both TGF-β PV and BAV more frequently had aortic valve surgery (17/30, 57% vs. 110/387, 28%, PR 1.99 [1.40-2.83], pLDS TGFBR1 and TGFBR2 , and is associated with accelerated aortic valve and aortic diseasebut does not confer an increased risk for aortic dissection. These observations highlight the potential benefits of genetic testing for BAV patients who have a family history of HTAD, a sinus of Valsalva aneurysm, or clinical features suggestive of LDS.Keywords
This publication has 34 references indexed in Scilit:
- The role of transforming growth factor beta in bicuspid aortic valve aortopathyIndian Journal of Thoracic and Cardiovascular Surgery, 2023
- HTAD patient pathway: Strategy for diagnostic work-up of patients and families with (suspected) heritable thoracic aortic diseases (HTAD). A statement from the HTAD working group of VASCERNEuropean Journal of Medical Genetics, 2022
- International Consensus Statement on Nomenclature and Classification of the Congenital Bicuspid Aortic Valve and Its Aortopathy, for Clinical, Surgical, Interventional and Research PurposesThe Annals of Thoracic Surgery, 2021
- Prevalence of Bicuspid Aortic Valve and Associated Aortopathy in Newborns in Copenhagen, DenmarkJAMA, 2021
- Rare deleterious variants of NOTCH1, GATA4, SMAD6, and ROBO4 are enriched in BAV with early onset complications but not in BAV with heritable thoracic aortic diseaseMolecular Genetics & Genomic Medicine, 2020
- Aortic Dilatation Associated With Bicuspid Aortic Valve: Relation to Sex, Hemodynamics, and Valve Morphology (the National Heart Lung and Blood Institute-Sponsored National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions)The American Journal of Cardiology, 2017
- Aortic Dissection in Patients With Bicuspid Aortic Valve–Associated AneurysmsThe Annals of Thoracic Surgery, 2015
- Incidence of Aortic Complications in Patients With Bicuspid Aortic ValvesJAMA, 2011
- Echocardiographic Assessment of Valve Stenosis: EAE/ASE Recommendations for Clinical PracticeJournal of the American Society of Echocardiography, 2009
- Outcomes in Adults With Bicuspid Aortic ValvesJAMA, 2008